IDT Australia Limited
Research IDT Australia Limited (IDT.AX) on Bullrun: market cap AUD 16.33M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIDT.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyAUD
- Market capAUD 16.33M
- Financial periodFY2026
- RevenueAUD 20.36M
- Revenue growth5.9%
- Net income-AUD 2.72M
- Free cash flow-AUD 243.00K
- Gross margin78.2%
Valuation Snapshot
latest market cap is AUD 16.33M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | AUD 20.36M | -AUD 2.72M | -AUD 243.00K | 78.2% | -0.01 | AUD 2.52M | AUD 10.83M | AUD 19.04M |
| FY2025 | AUD 19.22M | -AUD 8.06M | -AUD 7.55M | 68.2% | -0.02 | AUD 503.00K | AUD 10.41M | AUD 21.89M |
| FY2024 | AUD 13.23M | -AUD 5.41M | -AUD 10.30M | 78.8% | -0.02 | AUD 504.00K | AUD 4.47M | AUD 23.44M |
| FY2023 | AUD 6.94M | -AUD 8.50M | -AUD 8.42M | 68.6% | -0.03 | AUD 4.43M | AUD 740.00K | AUD 24.14M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 16.33M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About IDT Australia Limited
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers integrated services, including development, analytical testing, clinical packaging; and microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides formulation and manufacture of speciality orals (medicinal cannabis) and advanced therapies;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is IDT Australia Limited's market cap?
IDT Australia Limited's market capitalization is AUD 16.33M.
What does IDT Australia Limited do?
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers integrated services, including development, analytical testing, clinical packaging; and microbiological and analytical testing, clinical packaging, and pharmacy services.